Evaluation of the Preventive Effects of Carvedilol on Trastuzumab-Induced Cardiotoxicity in Early-Stage and Locally Advanced HER2-Positive Breast Cancer Patients

Background: Trastuzumab is an efficient monoclonal antibody used in the treatment of Her2-positive breast cancer. Despite its prominent effect on Her2-positive patients’ disease-free Survival. Trastuzumab-induced cardiotoxicity is still one of the main challenges. Angiotensin-converting enzyme inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Esfandbod, Mohsen, Naderi, Mina, Sadatnaseri, Azadeh, Ahmadi, Ayat, Noroozi, Mohammadtaghi, Sadeghi Joni, Saeid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888356/
https://www.ncbi.nlm.nih.gov/pubmed/35291664
http://dx.doi.org/10.18502/ijhoscr.v15i4.7475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888356/
https://www.ncbi.nlm.nih.gov/pubmed/35291664
http://dx.doi.org/10.18502/ijhoscr.v15i4.7475

Ejemplares similares